Patient P-02097

Synthetic patientMETA-24 · Day 129 · 25–34 · M · baseline S17Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

12%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17
Day 29 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 29.

Primary contributors, last 14 days

Inflammatory activity-9
Toxicity-5
Treatment adherence+4
GI instability-2
Nutritional resilience+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

37 min

improving · +10.4 vs previous 14 d

Sleep duration

Wearable

7.8 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.2/10

improving · +0.6 vs previous 14 d

Steps

Wearable

4,537

improving · +933 vs previous 14 d

GI burden

Companion

14.5/100

improving · -5.5 vs previous 14 d

Adherence

Companion

89.7 %

stable · -1.0 vs previous 14 d

Sleep quality

Wearable

70.2/100

improving · +5.3 vs previous 14 d

Glucose, CGM daily mean

CGM

124 mg/dL

stable · -1.2 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 81 from the failing basin, 16 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +14.9
Butyrate producers intact
hidden · steering +7.5
Histamine load (supports)
perturbation · steering +5.6
Protein
supporter · GI -7.9 next day
Histamine load
supporter · GI -3.5 next day

Main detractors to watch

Simple carbohydrates
perturbation · steering -11.3
Low microbial diversity
hidden · steering -7.7
Antibiotic course
perturbation · steering -4.7
Dietary fat load
perturbation · steering -4.6
Simple carbohydrates
detractor · GI +6.2 next day
Dietary fat load
detractor · GI +3.3 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-7.9supporter · 95%
Simple carbohydrates
+6.2detractor · 95%
Histamine load
-3.5supporter · 62%
Dietary fat load
+3.3detractor · 56%
Caffeine
+2.5no signal · 39%
Alcohol
+1.9no signal · 34%
Insoluble fibre
-1.6no signal · 26%
Ultra-processed food
+1.6no signal · 31%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 2.8 · butyrate capacity 54/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 46 ms
Sleep: 7.3 h
Steps: 4,426
Resting HR: 60 bpm

Daily log: GI score 15, nutritional resilience 69, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02031	35%	S12	AD-05	improved	47
P-02285	33%	S14	AD-05	no change	39
P-02483	44%	S06	BR-03	no change	64
P-02280	37%	S07	BR-03	no change	50
P-02267	36%	S09	BR-03	no change	45
P-02354	36%	S01	CR-01	improved	78
P-02518	49%	S17	DT-01	improved	68
P-02462	48%	S12	DT-01	improved	65
P-02491	47%	S09	DT-01	no change	65
P-02235	41%	S14	DT-01	improved	50
P-02218	38%	S01	DT-01	improved	61
P-02330	38%	S15	DT-01	no change	57